Literature DB >> 30290973

An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.

Arianna Mazzotti1, Maria Turchese Caletti1, Lucia Brodosi1, Silvia Di Domizio1, Maria Luisa Forchielli1, Salvatore Petta2, Elisabetta Bugianesi3, Giampaolo Bianchi1, Giulio Marchesini4.   

Abstract

BACKGROUND & AIMS: Interventions aimed at lifestyle changes are pivotal for the treatment of non-alcoholic fatty liver disease (NAFLD), and web-based programs might help remove barriers in both patients and therapists.
METHODS: In the period 2010-15, 716 consecutive NAFLD cases (mean age, 52; type 2 diabetes, 33%) were treated in our Department with structured programs. The usual protocol included motivational interviewing and a group-based intervention (GBI), chaired by physicians, dietitians and psychologists (five weekly meetings, n = 438). Individuals who could not attend GBI entered a web-based intervention (WBI, n = 278) derived from GBI, with interactive games, learning tests, motivational tests, and mail contacts with the center. The primary outcome was weight loss ≥10%; secondary outcomes were alanine aminotransferase within normal limits, changes in lifestyle, weight, alanine aminotransferase, and surrogate markers of steatosis and fibrosis.
RESULTS: GBI and WBI cohorts had similar body mass index (mean, 33 kg/m2), with more males (67% vs. 45%), younger age, higher education, and more physical activity in the WBI group. The two-year attrition rate was higher in the WBI group. Healthy lifestyle changes were observed in both groups and body mass index decreased by almost two points;the 10% weight target was reached in 20% of WBI cases vs. 15% in GBI (not significant). In logistic regression analysis, after adjustment for confounders and attrition rates, WBI was not associated with a reduction of patients reaching short- and long-term 10% weight targets. Liver enzymes decreased in both groups, and normalized more frequently in WBI. Fatty liver index was reduced, whereas fibrosis remained stable (NAFLD fibrosis score) or similarly decreased (Fib-4).
CONCLUSION: WBI is not less effective than common lifestyle programs, as measured by significant clinical outcomes associated with improved histological outcomes in NAFLD. eHealth programs may effectively contribute to NAFLD control. LAY
SUMMARY: In patients with non-alcoholic fatty liver disease, participation in structured lifestyle programs may be jeopardized by job and time constraints. A web-based intervention may be better suited for young, busy patients, and for those living far from liver units. The study shows that, following a structured motivational approach, a web-based, interactive intervention coupled with six-month face-to-face meetings is not inferior to a standard group-based intervention with respect to weight loss, adherence to healthy diet and habitual physical activity, normalization of liver enzymes, and stable surrogate markers of fibrosis.
Copyright © 2018 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diet; Liver enzymes; NAFLD progression; Physical activity

Mesh:

Substances:

Year:  2018        PMID: 30290973     DOI: 10.1016/j.jhep.2018.07.013

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  17 in total

1.  The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease.

Authors:  Mohammed Eslam; Shiv K Sarin; Vincent Wai-Sun Wong; Jian-Gao Fan; Takumi Kawaguchi; Sang Hoon Ahn; Ming-Hua Zheng; Gamal Shiha; Yusuf Yilmaz; Rino Gani; Shahinul Alam; Yock Young Dan; Jia-Horng Kao; Saeed Hamid; Ian Homer Cua; Wah-Kheong Chan; Diana Payawal; Soek-Siam Tan; Tawesak Tanwandee; Leon A Adams; Manoj Kumar; Masao Omata; Jacob George
Journal:  Hepatol Int       Date:  2020-10-01       Impact factor: 6.047

Review 2.  Using Telehealth for Diagnosis and Management of Non-Alcoholic Fatty Liver Disease.

Authors:  Hamid-Reza Moein; Elvis J Arteaga; Souvik Sarkar
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-04-29

3.  The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care.

Authors:  Wolf Peter Hofmann; Peter Buggisch; Lisa Schubert; Nektarios Dikopoulos; Jeannette Schwenzer; Marion Muche; Gisela Felten; Renate Heyne; Patrick Ingiliz; Anna Schmidt; Kerstin Stein; Heiner Wedemeyer; Thomas Berg; Johannes Wiegand; Frank Lammert; Stefan Zeuzem; Jörn M Schattenberg
Journal:  JHEP Rep       Date:  2020-08-04

4.  Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease.

Authors:  Audrey Thorp; Jonathan G Stine
Journal:  Curr Hepatol Rep       Date:  2020-09-09

5.  Telemedicine Improves Access to Hepatology Consultation with High Patient Satisfaction.

Authors:  Ezequiel Mauro; Sebastián Marciano; María C Torres; Juan D Roca; Abel L Novillo; Adrían Gadano
Journal:  J Clin Exp Hepatol       Date:  2020-05-05

Review 6.  Diet and exercise in NAFLD/NASH: Beyond the obvious.

Authors:  Georg Semmler; Christian Datz; Thomas Reiberger; Michael Trauner
Journal:  Liver Int       Date:  2021-08-21       Impact factor: 8.754

Review 7.  Importance of fatigue and its measurement in chronic liver disease.

Authors:  Lynn H Gerber; Ali A Weinstein; Rohini Mehta; Zobair M Younossi
Journal:  World J Gastroenterol       Date:  2019-07-28       Impact factor: 5.742

Review 8.  Lifestyle modification in NAFLD/NASH: Facts and figures.

Authors:  Kate Hallsworth; Leon A Adams
Journal:  JHEP Rep       Date:  2019-11-05

9.  Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial.

Authors:  Su Lin Lim; Jolyn Johal; Kai Wen Ong; Chad Yixian Han; Yiong Huak Chan; Yin Mei Lee; Wai Mun Loo
Journal:  JMIR Mhealth Uhealth       Date:  2020-04-13       Impact factor: 4.773

10.  Managing NAFLD in Type 2 Diabetes: The Effect of Lifestyle Interventions, a Narrative Review.

Authors:  Siôn A Parry; Leanne Hodson
Journal:  Adv Ther       Date:  2020-03-07       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.